Germany· DE-A57-288f5db2f835ce2a

Ebrantil

A urapidil product containing urapidil hydrochloride, registered in Germany by Cheplapharm Arzneimittel Gmbh. The same ATC class is registered in 10 of our 19 countries.

ATC C02CA06

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedEbrantilATCC02CA06REGISTER NO.DE-A57-288f5db2f835ce…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Urapidil is registered in 10 of 19 countries.

Countries holding a registration under ATC C02CA06 (urapidil), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 6 of them publish a price we can compare per daily dose

Urapidil · ATC C02CA06

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Urapidil Hydrochloride
Manufacturer
Cheplapharm Arzneimittel Gmbh
Country
Germany (DE)
ATC code
C02CA06
ATC class
Urapidil
Defined daily dose
0.12 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Urapidil in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All urapidil products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Ebrantil, Galluper
  • Belgium · Ebrantil I.V. 50
  • Czechia · Ebrantil, Ebrantil Retard
  • Estonia · Urapidil Kalceks
  • Spain · Urapidil Accord, Urapidil Kalceks
  • France · Eupressyl, Eupressyl Lp
  • Croatia · Ebrantil, Urapidil Kalceks
  • Hungary · Ebrantil, Urapidil Kalceks
  • Italy · Ebrantil, Urapidil Kalceks
  • Luxembourg · Ebrantil I.V.
  • Latvia · Urapidil Kalceks
  • Netherlands · Urapidil Kalceks
  • Poland · Ebrantil, Tachyben
  • Portugal · Urapidil Kalceks, Urapidilo
  • Romania · Tachyben, Urapidil Kalceks
  • Slovenia · Ebrantil, Urapidil Kalceks
  • Slovakia · Desurol, Ebrantil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/700941d0-3323-4772-aa2f-73a080f4b586
GET /v1/drugs/700941d0-3323-4772-aa2f-73a080f4b586?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Urapidil Hydrochloride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about urapidil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.